Similar articles

• Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.

  Levenstein JH. Levenstein JH. S Afr Med J. 1978 Nov 18;54(21):860-4. S Afr Med J. 1978. PMID: 371021 Clinical Trial.
• A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.

  Elsdon-Dew RW, Holden E. Elsdon-Dew RW, et al. J Int Med Res. 1981;9(5):315-8. doi: 10.1177/030006058100900503. J Int Med Res. 1981. PMID: 7028531 Clinical Trial. No abstract available.
• Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.

  Levenstein JH. Levenstein JH. S Afr Med J. 1981 Jun 13;59(25):893-9. S Afr Med J. 1981. PMID: 7015537 Clinical Trial.
• Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.

  Ebbut AF, Elsdon-Dew RW, Murphy JE. Ebbut AF, et al. J Int Med Res. 1978;6(6):494-8. doi: 10.1177/030006057800600615. J Int Med Res. 1978. PMID: 720740
• Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.

  Goble AJ. Goble AJ. Med J Aust. 1975 Jan 4;1(SP2):14-7. Med J Aust. 1975. PMID: 1124020